Gefitinib plus clocetaxel in non-small-cell lung cancer Reply

被引：0
|
作者：
Kim, Edward S. [1 ]
Watkins, Claire L. [2 ]
Armour, Alison A. [2 ]
Douillard, Jean-Yves [3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77401 USA
[2] AstraZeneca, Macclesfield, Cheshire, England
[3] Ctr Rene Gauducheau, F-44035 Nantes, France
来源：
LANCET | 2009年 / 373卷 / 9663期
关键词：
D O I：
10.1016/S0140-6736(09)60195-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：542 / 542
页数：1
相关论文
共 50 条
  • [1] Gefitinib plus clocetaxel in non-small-cell lung cancer
    Costa, Daniel B.
    Kobayashi, Susumu
    [J]. LANCET, 2009, 373 (9663): : 541 - 541
  • [2] Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer REPLY
    Cataldo, Vince D.
    Gibbons, Don L.
    Quintas-Cardama, Alfonso
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2368 - 2368
  • [3] Gefitinib maintenance in stage III non-small-cell lung cancer - Reply
    Kelly, Karen
    Redman, Mary W.
    Gandara, David R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) : 4850 - 4851
  • [4] Gefitinib for the treatment of non-small-cell lung cancer
    Campbell, Lynn
    Blackhall, Fiona
    Thatcher, Nicholas
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (08) : 1343 - 1357
  • [5] Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer
    Yusuf, Syed W.
    Kim, Peter
    Durand, Jean-Bernard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2367 - 2367
  • [6] Gefitinib for the treatment of non-small-cell lung cancer
    Hida, Toyoaki
    Ogawa, Shizu
    Park, Jang Chul
    Park, Ji Young
    Shimizu, Junichi
    Horio, Yoshitsugu
    Yoshida, Kimihide
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (01) : 17 - 35
  • [7] Spotlight on gefitinib in non-small-cell lung cancer
    Frampton, JE
    Easthope, SE
    [J]. AMERICAN JOURNAL OF PHARMACOGENOMICS, 2005, 5 (02) : 133 - 136
  • [8] Gefitinib for non-small-cell lung cancer treatment
    D'Incecco, Armida
    Cappuzzo, Federico
    [J]. EXPERT OPINION ON DRUG SAFETY, 2011, 10 (06) : 987 - 996
  • [9] Nivolumab plus Ipilimumab in Non-Small-Cell Lung Cancer Reply
    Hellmann, Matthew D.
    Ramalingam, Suresh S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (09): : 875 - 875
  • [10] Gefitinib in the treatment of advanced non-small-cell lung cancer
    Reck, Martin
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 401 - 412
12345